Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-25
2011-01-25
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S236200, C514S236500, C544S122000, C544S124000, C544S133000, C544S134000, C544S137000, C544S140000
Reexamination Certificate
active
07875609
ABSTRACT:
The present invention provides compounds of Formula (I):in which R1, R′1, R2, R′2, R3, and Y have the meanings given in the description are useful in the treatment of conditions susceptible to modulating ion channels, to a process for their preparation, their application by way of medicaments, and to pharmaceutical compositions containing them.
REFERENCES:
patent: 3897242 (1975-07-01), Martin
patent: 4521583 (1985-06-01), Kohli
patent: 4579947 (1986-04-01), Devlin et al.
patent: 4594373 (1986-06-01), Kohli
patent: 5227397 (1993-07-01), Saccomano et al.
patent: 5242947 (1993-09-01), Cherksey et al.
patent: 5312928 (1994-05-01), Goldin et al.
patent: 5849732 (1998-12-01), Suzuki et al.
patent: 5891912 (1999-04-01), Kawashima et al.
patent: 5968980 (1999-10-01), Kawashima et al.
patent: 6011068 (2000-01-01), Nemeth et al.
patent: 6022894 (2000-02-01), Del Mar et al.
patent: 6031003 (2000-02-01), Nemeth et al.
patent: 6211244 (2001-04-01), Van Wagenen et al.
patent: 6221913 (2001-04-01), Petrie et al.
patent: 6313146 (2001-11-01), Van Wagenen et al.
patent: 6596746 (2003-07-01), Das et al.
patent: 7084167 (2006-08-01), Ruat et al.
patent: 7157498 (2007-01-01), Dauban et al.
patent: 7585886 (2009-09-01), Hachiya et al.
patent: 7605261 (2009-10-01), DePrez et al.
patent: 2004/0053925 (2004-03-01), Deprez et al.
patent: 2004/0082588 (2004-04-01), Evans et al.
patent: 2007/0173502 (2007-07-01), DePrez et al.
patent: 2008/0125424 (2008-05-01), DePrez et al.
patent: 2009/0054463 (2009-02-01), DePrez et al.
patent: 2009/0062366 (2009-03-01), Hachiya et al.
patent: 0415413 (1991-03-01), None
patent: 58-109464 (1983-06-01), None
patent: 08-041006 (1996-02-01), None
patent: 09-012455 (1997-01-01), None
patent: 10-195037 (1998-07-01), None
patent: 11-139969 (1999-05-01), None
patent: WO 92/08700 (1992-05-01), None
patent: WO 93/23368 (1993-11-01), None
patent: WO 94/14436 (1994-07-01), None
patent: WO 95/11221 (1995-04-01), None
patent: WO 96/12697 (1996-05-01), None
patent: WO 97/37967 (1997-10-01), None
patent: WO 99/07672 (1999-02-01), None
patent: WO 00/62778 (2000-10-01), None
patent: WO 01/00576 (2001-01-01), None
patent: WO 02/059102 (2002-08-01), None
patent: WO 2004/030669 (2004-04-01), None
patent: WO 2005/115975 (2005-12-01), None
patent: WO 2006/117211 (2006-11-01), None
patent: WO 2006/123725 (2006-11-01), None
patent: WO 2007/060026 (2007-05-01), None
patent: WO 2008/006625 (2008-01-01), None
patent: WO 2009/009122 (2009-01-01), None
Nemeth et al., “Pharmacological Regulation of Parathyroid Hormone Secretion”, Current Pharmaceutical Design, pp. 2077-2087, 8, 2002.
Cho et al. (1999) “Bioisosterism: Interchange of 4-OH to 4-NH2 in Vanillin or Homovanillin Ring of Capsaicinoids,”Arch. Pharm. Res.22(2):184-188.
Golub, T.R. et al. (1999) “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring” Science vol. 286 pp. 531-537.
Huff, J.R. (Aug. 1991) “HIV Protease: A Novel Chemotherapeutic Target for AIDS”J. Med. Chem.34(8):2305-2314.
Kuklin (1996) “Preparation and Pharmacological Properties of Sulfur-Containing Amides of Dicarboxylic Acids,” CAPLUS Accession No. 1996:369326.
Kuro et al. (2000) “Effects of SA7060, a Novel Dual Inhibitor of Neutral Endopeptidase and Angiotensin-Converting Enzyme, on Deoxycorticosterone Acetate-Salt-Induced Hypertension in Rats,”Biol. Pharm. Bull.23(7):820-825.
Lala et al. (1998) “Role of Nitric Oxide in Tumor Progression: Lessons from Experimental Tumors,”Cancer Metastasis Rev.17:91-106.
Muller et al. (1977) “Boron Compounds. 7. Synthesis and Molecular Structure of 1,5-Diethyl-2,3-Diphenyl-1,3,5-Triaza-2-Bora-Cyclooctane-4-One: The Product of Aminoboronation,”Z. Anorg. Allg. Chem.433:268-274.
Munroe et al. et al. (1995) “Potent, Orally Bioavailable HIV-1 Protease Inhibitors Containing Noncoded D-Amino Acids,”Bioorg. Med. Chem. Lett.5(23):2897-2902.
Nomura et al (1998) “Synthesis of Physiologically Active Substances. 19. Synthesis and Pesticidal Activity of Ureas and Amides with Bicyclic Monoterpenyl Derivatives (mites),” CAPLUS Accession No. 1998:757076.
Nowick et al. (1992) “Molecular Scaffolds I: Intramolecular Hydrogen Bonding in a Family of Di- and Triureas,”J. Org. Chem.57:3763-3765.
Nowick et al. (1997) “The Propensities of Amino Acids to Form Parallel β-Sheets,”J. Am. Chem. Soc.119:10903-10908.
Nowick et al. (1995) “Molecular Scaffolds. 2. Intramolecular Hydrogen Bonding in 1,2-Diaminoethane Diureas,”J. Am. Chem. Soc.117:89-99.
Uribe et al. (1979) “Rotational Isomerism of 1-Dicyclohexyl-3-tert-butyl Urea in the Solid State,” CAPLUS Accession No. 1979:203395.
Vaino et al. (Jul. 5, 2000) “Euclidean Shape-Encoded Combinatorial Chemical Libraries,”Proc. Nat. Acad. Sci.USA 97(14):7692-7696.
CNN web page, URL: http://www.cnn.com/2003/HEALTH/conditions/09/24/alzheimers.drug.ap/index.html Retrieved Aug. 19, 2010 (Way back Machine).
International Search Report of WO 02/059102, 2002.
Deprez Pierre
Jary Hélène
Temal Taoues
Anderson Rebecca L
Galapagos Sasu
Greenlee Sullivan P.C.
LandOfFree
Urea derivatives, processes for their preparation, their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea derivatives, processes for their preparation, their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea derivatives, processes for their preparation, their use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2681550